0001181431-14-004179.txt : 20140128
0001181431-14-004179.hdr.sgml : 20140128
20140128173936
ACCESSION NUMBER: 0001181431-14-004179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140127
FILED AS OF DATE: 20140128
DATE AS OF CHANGE: 20140128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hung David
CENTRAL INDEX KEY: 0001310880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 14554100
MAIL ADDRESS:
STREET 1: 501 SECOND STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
rrd400763.xml
1/27/2014 -- SALE PURSUANT TO 10B-5PLAN
X0306
4
2014-01-27
0
0001011835
MEDIVATION, INC.
MDVN
0001310880
Hung David
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
1
0
0
President and CEO
Common Stock
2014-01-27
4
M
0
150000
5.88
A
1100204
D
Common Stock
2014-01-27
4
S
0
11000
71.77
D
1089204
D
Common Stock
2014-01-27
4
S
0
61823
72.99
D
1027381
D
Common Stock
2014-01-27
4
S
0
62577
73.72
D
964804
D
Common Stock
2014-01-27
4
S
0
1700
74.75
D
963104
D
Common Stock
2014-01-27
4
S
0
9900
76.15
D
953204
D
Common Stock
2014-01-27
4
S
0
3000
76.43
D
950204
D
Common Stock
86060
I
By trust
Employee Stock Option (right to buy)
5.88
2014-01-27
4
M
0
300000
0
D
2016-10-31
Common Stock
300000
50000
D
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $71.27 to $72.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $72.31 to $73.305. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $73.32 to $74.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $74.34 to $75.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $75.385 to $76.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $76.40 to $76.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
/s/ Patrick Machado, Attorney-in-fact
2014-01-28